We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Curis Inc
49 own
48 watching
Current Price
$0.76
$0
(-0.61%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
72.79M
52-Week High
3.755
52-Week Low
0.47
Average Volume
0.36M
Dividend Yield
--
P/E Ratio
--
Market Capitalization72.79M52-Week High3.75552-Week Low0.47Average Volume0.36MDividend Yield--P/E Ratio--What does the Curis Inc do?
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase II clinical trials for relapsed or refractory diffuse large B-cell lymphoma, as well as in Phase I clinical trials for patients with solid tumors; CA-170, an oral small molecule drug candidate that is in Phase I clinical trials in patients with advanced solid tumors and lymphomas; CA-4948, an oral small molecule drug candidate, which is in preclinical stage for the treatment of hematologic cancers; and CA-327, an oral small molecule drug candidate that is in preclinical stage for the treatment of cancers. It is also developing Erivedge, an orally-administered small molecule hedgehog pathway inhibitor for advanced basal cell carcinoma, idiopathic pulmonary fibrosis, and myelofibrosis. The company has collaboration agreement with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and collaboration and license agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge. Curis, Inc. was founded in 2000 and is headquartered in Lexington, Massachusetts.
Read More
How much money does Curis Inc make?
News & Events about Curis Inc.
Zolmax
21days ago
StockNews.com began coverage on shares of Curis (NASDAQ:CRIS Get Rating) in a research note published on Thursday. The brokerage issued a hold rating on the biotechnology companys stock. Other equities analysts also recently issued reports about the company. HC Wainwright cut their target price on ...
Ticker Report
21days ago
StockNews.com began coverage on shares of Curis (NASDAQ:CRIS Get Rating) in a research note published on Thursday. The brokerage issued a hold rating on the biotechnology companys stock. Other equities analysts also recently issued reports about the company. HC Wainwright cut their ...
PR Newswire
1month ago
Curis Announces Additional Encouraging Clinical Data from TakeAim Leukemia Study of emavusertib (CA-4948) in Monotherapy R/R AML and hrMDS Curis Announces Additional Encouraging Clinical Data from TakeAim Leukemia Study of emavusertib (CA-4948) in Monotherapy R/R AML and hrMDS PR Newswire...
PR Newswire
1month ago
Curis to Host Webcast to Discuss Updated Emavusertib Clinical Data in Leukemia Curis to Host Webcast to Discuss Updated Emavusertib Clinical Data in Leukemia PR Newswire LEXINGTON, Mass., Dec. 5, 2022 Curis to review results during conference call, featuring commentaryby Dr. Eric Winer, M.D...
PR Newswire
4 months ago
Curis Announces Date for the 2nd Annual VISTA Symposium Curis Announces Date for the 2nd Annual VISTA Symposium PR Newswire LEXINGTON, Mass., Sept. 19, 2022 Industry experts in immuno-oncology will gather to discuss VISTA on September 23, 2022 Symposium hosted by Randolph Noelle, Ph.D. LEXINGTON...
Frequently Asked Questions
Frequently Asked Questions
What is Curis Inc share price today?
Can Indians buy Curis Inc shares?
How can I buy Curis Inc shares from India?
Can Fractional shares of Curis Inc be purchased?
What are the documents required to start investing in Curis Inc stocks?
What is today’s traded volume of Curis Inc?
What is today’s market capitalisation of Curis Inc?
What is the 52-Week High and Low Range of Curis Inc?
What percentage is Curis Inc down from its 52-Week High?
What percentage is Curis Inc up from its 52-Week Low?
Current Price
$0.76
$0
(-0.61%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.